Investment Details
Investor Type
Private Investment Firm
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Early Stage, Growth, Late Stage, Pre-IPO, Buyout
Geographical Focus
United States
Industries Focus
- Healthcare
- Biotechnology
Investment Size:
10,000,000 to 500,000,000 USD
Investor Details Founded: 2017
Eversept Partners is a New York-based investment firm specializing in healthcare and biotech sectors across the United States. The firm focuses on private equity and venture capital investments, targeting early-stage to pre-IPO companies, as well as buyouts. Their investment strategy emphasizes identifying and nurturing innovative companies within the healthcare and biotechnology industries.
The firm's portfolio includes a range of companies in the healthcare and biotech sectors, reflecting their commitment to advancing these industries. Eversept Partners has a history of managing substantial assets, with filings indicating investments ranging from $10 million to over $500 million. This track record demonstrates their capacity to support companies at various stages of development.
Eversept Partners is led by a team of experienced professionals, including founder and Chief Investment Officer Kamran Moghtaderi, Chief Operating Officer Balkir Zihnali, Chief Financial Officer Ron Rosenstraus, and Controller Andrew Rose. The firm's leadership is dedicated to driving growth and innovation in the healthcare and biotech sectors through strategic investments and partnerships.
Requirements
- Innovative healthcare and biotech companies
- Early-stage to pre-IPO opportunities
- Potential for significant growth and impact
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Cabaletta Bio, Inc.
Claim this Investor
Are you an official representative of Eversept Partners?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim